Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep537 | Diabetes complications | ECE2017

PDE5i preserves renal function in models of Diabetic Nephropathy: from bench to bedside

Pofi Riccardo , Fiore Daniela , Feola Tiziana , Giannetta Elisa , Grazie Giulia Le , Dato Carla Di , Gianfrilli Daniele , Barbano Biagio , Venneri Mary A. , Lenzi Andrea , Isidori Andrea M.

One third of diabetic patients suffer from Diabetic Nephropathy (DN) that leads to end-stage renal disease (ESRD). The molecular pathways involved remain underexplored. We showed that chronic phosphodiesterase-5 inhibition (PDE5i) improve vascular inflammation [1] and tissue remodelling, reducing proteinuria [2] in murine diabetes. Our aim was to investigate the effect of PDE5i on animal and human models of DN.Materials and methods: 16 mice were randomly...